Retrospective analysis of the cohort of patients with anxiety, obsessive-compulsive and obsessive-compulsive related disorders at the departement of psychiatry and psychotherapy

Retrospective analysis of the cohort of patients with anxiety, obsessive-compulsive and obsessive-compulsive related disorders at the departement of psychiatry and psychotherapy - A-O-retro

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037276

Enrollment

1000

Registered

2025-10-06

Start date

2025-10-06

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, obsessive-compulsive and compulsive spectrum disorders

Interventions

Group 1: Retrospective analysis of three patient cohorts with related disorders

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Data from patients with all anxiety, obsessive-compulsive and obsessive-compulsive spectrum disorders treated at the Department of Psychiatry and Psychotherapy, University Medical Center Freiburg, both as outpatients and, above all, as (partial) inpatients, should be analyzed. Patients with anxiety, obsessive-compulsive and compulsive spectrum disorders with organic causes or as a result of substance use should also be explicitly analyzed. Comorbidities are also not an exclusion criterion. Only patients aged = 18 years should be analyzed. Patients from 2000 at the earliest until July 2025 should be included. For the subproject regarding tissue-based assay findings, all patients > 18 years of age who have received a corresponding analysis from CSF/serum pairs since 2018 should be included transdiagnostically.

Exclusion criteria

Exclusion criteria: <18 years

Design outcomes

Primary

Measure	Time frame
Number of secondary anxiety, obsessive-compulsive and obsessive-compulsive related disorders per group	—

Secondary

Measure	Time frame
Clinical description of the patient groups Abnormalities in clinical laboratory findings CSF alterations EEG pathologies (a. clinical findings, b. automatically analyzed data in comparison to existing controls) MRI findings (a. clinical findings, b. automatically analyzed data in comparison to existing control groups) FDG-PET pathologies (if examined) Treatment response in the naturalistic setting Abnormalities in the multimodal diagnostic-work up Number of abnormal antibody screening tests in CSF/serum (in transdiagnostic comparison)	—

Measure

Time frame

Clinical description of the patient groups Abnormalities in clinical laboratory findings CSF alterations EEG pathologies (a. clinical findings, b. automatically analyzed data in comparison to existing controls) MRI findings (a. clinical findings, b. automatically analyzed data in comparison to existing control groups) FDG-PET pathologies (if examined) Treatment response in the naturalistic setting Abnormalities in the multimodal diagnostic-work up Number of abnormal antibody screening tests in CSF/serum (in transdiagnostic comparison)

—

Countries

Germany

Contacts

Public ContactDominique Endres

Universitätsklinikum Freiburg, Klinik für Psychiatrie und Psychotherapie

dominique.endres@uniklinik-freiburg.de0761-27065010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026